DK3484892T3 - 1,2,4-triazolo-[3,4-b]-1,3,4-thiadiazolderivater - Google Patents

1,2,4-triazolo-[3,4-b]-1,3,4-thiadiazolderivater Download PDF

Info

Publication number
DK3484892T3
DK3484892T3 DK17742219.3T DK17742219T DK3484892T3 DK 3484892 T3 DK3484892 T3 DK 3484892T3 DK 17742219 T DK17742219 T DK 17742219T DK 3484892 T3 DK3484892 T3 DK 3484892T3
Authority
DK
Denmark
Prior art keywords
triazolo
thiadiazole derivatives
thiadiazole
derivatives
Prior art date
Application number
DK17742219.3T
Other languages
English (en)
Inventor
Dimitrios Trafalis
Original Assignee
Galenica S A
Energonbio Tech S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galenica S A, Energonbio Tech S A filed Critical Galenica S A
Application granted granted Critical
Publication of DK3484892T3 publication Critical patent/DK3484892T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/433—Thidiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK17742219.3T 2016-07-14 2017-07-14 1,2,4-triazolo-[3,4-b]-1,3,4-thiadiazolderivater DK3484892T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GR20160100380A GR1009565B (el) 2016-07-14 2016-07-14 Νεα παραγωγα 1,2,4-τριαζολο-[3,4-b]-1,3,4-θειαδιαζολιων
PCT/EP2017/067908 WO2018011414A1 (en) 2016-07-14 2017-07-14 NEW 1,2,4-TRIAZOLO-[3,4-b]-1,3,4-THIADIAZOLE DERIVATIVES

Publications (1)

Publication Number Publication Date
DK3484892T3 true DK3484892T3 (da) 2020-11-16

Family

ID=58314472

Family Applications (1)

Application Number Title Priority Date Filing Date
DK17742219.3T DK3484892T3 (da) 2016-07-14 2017-07-14 1,2,4-triazolo-[3,4-b]-1,3,4-thiadiazolderivater

Country Status (19)

Country Link
US (1) US10513529B2 (da)
EP (1) EP3484892B1 (da)
JP (1) JP7005588B2 (da)
KR (1) KR102492136B1 (da)
CN (1) CN109689660B (da)
AU (1) AU2017296088B2 (da)
CA (1) CA3030493C (da)
CY (1) CY1123869T1 (da)
DK (1) DK3484892T3 (da)
ES (1) ES2831301T3 (da)
GR (1) GR1009565B (da)
HR (1) HRP20201793T1 (da)
HU (1) HUE051576T2 (da)
LT (1) LT3484892T (da)
PT (1) PT3484892T (da)
RS (1) RS61112B1 (da)
RU (1) RU2765180C2 (da)
SI (1) SI3484892T1 (da)
WO (1) WO2018011414A1 (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7287606B2 (ja) 2018-08-10 2023-06-06 株式会社日本スペリア社 鉛フリーはんだ合金

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007034510A1 (en) * 2005-09-21 2007-03-29 Jawaharlal Nehru Centre For Advanced Scientific Research Derivatives of 4,6-disubstituted 1,2,4-triazolo-1,3,4-thiadiazole, a process and uses thereof
KR20080080584A (ko) * 2005-11-30 2008-09-04 버텍스 파마슈티칼스 인코포레이티드 ｃ-Ｍｅｔ의 억제제 및 이의 용도
US7732468B2 (en) * 2006-11-15 2010-06-08 Cytovia, Inc. 3-aryl-6-aryl-[ 1,2,4]triazolo[3,4-b][1,3,4]thiadiazoles and related compounds as activators of caspases and inducers of apoptosis and the use thereof
CA2688823A1 (en) * 2007-05-21 2008-11-27 Sgx Pharmaceuticals, Inc. Heterocyclic kinase modulators
CA2762186A1 (en) * 2009-05-28 2010-12-02 Vertex Pharmaceuticals Incorporated Substituted pyrazole inhibitors of c-met protein kinase

Also Published As

Publication number Publication date
CY1123869T1 (el) 2022-03-24
GR1009565B (el) 2019-08-06
SI3484892T1 (sl) 2021-01-29
AU2017296088A1 (en) 2019-02-21
RU2765180C2 (ru) 2022-01-26
US20190194228A1 (en) 2019-06-27
AU2017296088B2 (en) 2020-10-22
HUE051576T2 (hu) 2021-03-01
RU2019103997A (ru) 2020-08-14
KR20190030705A (ko) 2019-03-22
EP3484892B1 (en) 2020-08-26
RS61112B1 (sr) 2020-12-31
US10513529B2 (en) 2019-12-24
PT3484892T (pt) 2020-11-05
CN109689660A (zh) 2019-04-26
JP2019521146A (ja) 2019-07-25
CA3030493A1 (en) 2018-01-18
LT3484892T (lt) 2021-01-25
KR102492136B1 (ko) 2023-01-26
JP7005588B2 (ja) 2022-02-10
GR20160100380A (el) 2018-03-30
WO2018011414A1 (en) 2018-01-18
HRP20201793T1 (hr) 2020-12-25
RU2019103997A3 (da) 2020-09-30
EP3484892A1 (en) 2019-05-22
CN109689660B (zh) 2021-08-10
ES2831301T3 (es) 2021-06-08
CA3030493C (en) 2023-04-04

Similar Documents

Publication Publication Date Title
DK3355884T3 (da) Tetrahydro-1h-pyrido[3,4-b]indol-antiøstrogenlægemidler
LT3478682T (lt) [1,2,4]triazolo[1,5-a]piridinilu pakeisti indolo junginiai
DK3522715T3 (da) Mikrobiocide oxadiazolderivativer
EP3452481A4 (en) IMIDAZO [1,2-B] SUBSTITUTED PYRIDAZINES, IMIDAZO [1,5-B] SUBSTITUTED PYRIDAZINES, RELATED COMPOUNDS AND THEIR USE IN THE TREATMENT OF MEDICAL CONDITIONS
BR112018002709A2 (pt) derivados heterobicíclicos microbicidas
BR112017020349A2 (pt) derivados heterobicíclicos microbicidas
PL3099687T3 (pl) Makrocykle z heterocyklicznymi grupami p2' jako inhibitory czynnika xia
DK3172209T3 (da) Tabletformulering med 2-fluor-n-methyl-4-[7-(quinolin-6-ylmethyl)imidazo[1,2-b][1,2,4]triazin-2-yl]benzamid
IL247833B (en) 2-(2,4-difluorophenyl)-1,1-difluoro-1-(5-converted-pyridin-2-yl)-3-(1h-tetrazol-1-yl)propan-2-ols and processes for their preparation
DK3189056T3 (da) Cytotoksiske benzodiazepinderivater
PL3359543T3 (pl) Pochodne kukurbiturylu
BR112017022683A2 (pt) derivados policíclicos com heterociclos de anéis com cinco membros substituídos por enxofre ativos em termos pesticidas.
ZA201606386B (en) 2-(2,4-difluorophenyl)-1,1-difluoro-1-(5-substituted-pyridin-2-yl)-3-(1h-tetrazol-1-yl)propan-2-ols and processes for their preparation
BR112017022919A2 (pt) derivados policíclicos com heterociclos de anéis com cinco membros substituídos por enxofre ativos em termos pesticidas.
LT3402792T (lt) Chinolin-2-ono dariniai
LT3457851T (lt) Sobetiromo dariniai
LT3353177T (lt) Tricikliniai heterociklai, skirti vėžio gydymui
IL263172A (en) The history of three-ring heterocycles, their preparation and use
LT3402782T (lt) 8-amino-2-okso-1,3-diaza-spiro-[4.5]-dekano dariniai
LT3625224T (lt) N-pakeistieji indolo dariniai
IL267145B (en) Spiropyridine derivatives
IL287405A (en) Methods of preparing cytotoxic benzodiazepine derivatives
PL3490739T3 (pl) Modułowa wytwornica korpusów puszek
EP3548397C0 (en) DRINK POUCH
DK3368519T3 (da) Hidtil ukendte, heterocykliske antiøstrogener